title: Subcutaneous cavernous hemangioma visualized on an indium-111-octreotide scan.
abstract: Indium-111-octreotide, a somatostatin analog is the first commercially available receptor-based agent. It shares the binding site of naturally occurring somatostatin and is suitable for imaging somatostatin receptor-bearing tumors. An 111In-octreotide scan performed on a 6-wk old girl showed increased uptake in a subcutaneous cavernous hemangioma, which should be added to the list of lesions that can be visualized on an octreotide scan.
authors.affiliation: Department of Radiology, Saint Francis Medical Center, Peoria, Illinois, USA.
authors.forename: P F
authors.initials: PF
authors.lastname: Winter
authors.forename: J
authors.initials: J
authors.lastname: Lapke
authors.forename: R
authors.initials: R
authors.lastname: Winek
mesh_terms: D005260:Female; D006392:Hemangioma, Cavernous / Q000000981:diagnostic imaging*; D006801:Humans; D007205:Indium Radioisotopes; D007223:Infant; D015282:Octreotide / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000032:analysis*; D012983:Soft Tissue Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D007205:Indium Radioisotopes; D017481:Receptors, Somatostatin; C094279:indium-111-octreotide; D015282:Octreotide